A detailed history of Hyman Charles D transactions in Danaher Corp stock. As of the latest transaction made, Hyman Charles D holds 7,736 shares of DHR stock, worth $1.88 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
7,736
Previous 7,736 -0.0%
Holding current value
$1.88 Million
Previous $1.93 Million 0.05%
% of portfolio
0.11%
Previous 0.11%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 04, 2023

BUY
$239.75 - $277.0 $191,560 - $221,323
799 Added 11.52%
7,736 $1.95 Million
Q3 2022

Nov 09, 2022

BUY
$247.06 - $1507.4 $2,717 - $16,581
11 Added 0.16%
6,937 $1.79 Million
Q2 2022

Aug 02, 2022

BUY
$237.11 - $299.66 $71,133 - $89,898
300 Added 4.53%
6,926 $1.76 Million
Q3 2021

Nov 09, 2021

BUY
$272.21 - $332.43 $9,799 - $11,967
36 Added 0.55%
6,626 $2.02 Million
Q2 2021

Aug 05, 2021

BUY
$225.08 - $271.69 $78,778 - $95,091
350 Added 5.61%
6,590 $1.77 Million
Q1 2021

Apr 28, 2021

SELL
$212.38 - $245.9 $3,822 - $4,426
-18 Reduced 0.29%
6,240 $1.4 Million
Q4 2020

Feb 08, 2021

SELL
$212.5 - $245.46 $18,487 - $21,355
-87 Reduced 1.37%
6,258 $1.39 Million
Q3 2020

Oct 26, 2020

SELL
$177.16 - $215.33 $9,389 - $11,412
-53 Reduced 0.83%
6,345 $1.37 Million
Q2 2020

Aug 06, 2020

BUY
$128.7 - $176.83 $559,201 - $768,326
4,345 Added 211.64%
6,398 $1.13 Million
Q1 2020

Apr 30, 2020

BUY
$121.39 - $169.05 $19,179 - $26,709
158 Added 8.34%
2,053 $284,000
Q4 2019

Feb 03, 2020

SELL
$133.47 - $153.48 $4,671 - $5,371
-35 Reduced 1.81%
1,895 $291,000
Q3 2019

Nov 07, 2019

SELL
$135.4 - $146.47 $47,796 - $51,703
-353 Reduced 15.46%
1,930 $279,000
Q2 2019

Jul 24, 2019

BUY
$124.88 - $143.73 $285,101 - $328,135
2,283 New
2,283 $326,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $177B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Hyman Charles D Portfolio

Follow Hyman Charles D and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hyman Charles D, based on Form 13F filings with the SEC.

News

Stay updated on Hyman Charles D with notifications on news.